These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 11282915)

  • 1. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Ridker PM
    Circulation; 2001 Apr; 103(13):1813-8. PubMed ID: 11282915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.
    Ward-Caviness CK; Xu T; Aspelund T; Thorand B; Montrone C; Meisinger C; Dunger-Kaltenbach I; Zierer A; Yu Z; Helgadottir IR; Harris TB; Launer LJ; Ganna A; Lind L; Eiriksdottir G; Waldenberger M; Prehn C; Suhre K; Illig T; Adamski J; Ruepp A; Koenig W; Gudnason V; Emilsson V; Wang-Sattler R; Peters A
    Heart; 2017 Aug; 103(16):1278-1285. PubMed ID: 28255100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary High-Sensitivity C-Reactive Protein and Its Clinical Relevance in Modern Medicine: A Comprehensive Review.
    Bedi GN; Acharya S; Kumar S; Mapari SA
    Cureus; 2024 Apr; 16(4):e58165. PubMed ID: 38741881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
    Ridker PM; Cushman M; Stampfer MJ; Tracy RP; Hennekens CH
    N Engl J Med; 1997 Apr; 336(14):973-9. PubMed ID: 9077376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Test in Context: High-Sensitivity C-Reactive Protein.
    Ridker PM
    J Am Coll Cardiol; 2016 Feb; 67(6):712-723. PubMed ID: 26868696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, fibrinogen, and cardiovascular disease prediction.
    ; Kaptoge S; Di Angelantonio E; Pennells L; Wood AM; White IR; Gao P; Walker M; Thompson A; Sarwar N; Caslake M; Butterworth AS; Amouyel P; Assmann G; Bakker SJ; Barr EL; Barrett-Connor E; Benjamin EJ; Björkelund C; Brenner H; Brunner E; Clarke R; Cooper JA; Cremer P; Cushman M; Dagenais GR; D'Agostino RB; Dankner R; Davey-Smith G; Deeg D; Dekker JM; Engström G; Folsom AR; Fowkes FG; Gallacher J; Gaziano JM; Giampaoli S; Gillum RF; Hofman A; Howard BV; Ingelsson E; Iso H; Jørgensen T; Kiechl S; Kitamura A; Kiyohara Y; Koenig W; Kromhout D; Kuller LH; Lawlor DA; Meade TW; Nissinen A; Nordestgaard BG; Onat A; Panagiotakos DB; Psaty BM; Rodriguez B; Rosengren A; Salomaa V; Kauhanen J; Salonen JT; Shaffer JA; Shea S; Ford I; Stehouwer CD; Strandberg TE; Tipping RW; Tosetto A; Wassertheil-Smoller S; Wennberg P; Westendorp RG; Whincup PH; Wilhelmsen L; Woodward M; Lowe GD; Wareham NJ; Khaw KT; Sattar N; Packard CJ; Gudnason V; Ridker PM; Pepys MB; Thompson SG; Danesh J
    N Engl J Med; 2012 Oct; 367(14):1310-20. PubMed ID: 23034020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
    Ridker PM; Rifai N; Rose L; Buring JE; Cook NR
    N Engl J Med; 2002 Nov; 347(20):1557-65. PubMed ID: 12432042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
    ; Kaptoge S; Di Angelantonio E; Lowe G; Pepys MB; Thompson SG; Collins R; Danesh J
    Lancet; 2010 Jan; 375(9709):132-40. PubMed ID: 20031199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?
    Sellmayer A; Limmert T; Hoffmann U
    Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of C-reactive protein for cardiovascular disease detection and prevention.
    Ridker PM
    Circulation; 2003 Jan; 107(3):363-9. PubMed ID: 12551853
    [No Abstract]   [Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O; Mohanty BD; Martin SS; Joshi PH; Blaha MJ; Nasir K; Blumenthal RS; Budoff MJ
    J Am Coll Cardiol; 2013 Jul; 62(5):397-408. PubMed ID: 23727085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.
    Ridker PM; Buring JE; Cook NR; Rifai N
    Circulation; 2003 Jan; 107(3):391-7. PubMed ID: 12551861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM
    J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis--an inflammatory disease.
    Ross R
    N Engl J Med; 1999 Jan; 340(2):115-26. PubMed ID: 9887164
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of C-reactive protein on disease risk and its relation to dietary factors.
    Nanri A; Moore MA; Kono S
    Asian Pac J Cancer Prev; 2007; 8(2):167-77. PubMed ID: 17696726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and atherosclerosis.
    Libby P; Ridker PM; Maseri A
    Circulation; 2002 Mar; 105(9):1135-43. PubMed ID: 11877368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
    Pearson TA; Mensah GA; Alexander RW; Anderson JL; Cannon RO; Criqui M; Fadl YY; Fortmann SP; Hong Y; Myers GL; Rifai N; Smith SC; Taubert K; Tracy RP; Vinicor F; ;
    Circulation; 2003 Jan; 107(3):499-511. PubMed ID: 12551878
    [No Abstract]   [Full Text] [Related]  

  • 18. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.
    Ridker PM; Buring JE; Shih J; Matias M; Hennekens CH
    Circulation; 1998 Aug; 98(8):731-3. PubMed ID: 9727541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
    Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; MacFadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    N Engl J Med; 2008 Nov; 359(21):2195-207. PubMed ID: 18997196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.